{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:11:35Z","timestamp":1779347495079,"version":"3.51.4"},"reference-count":21,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.2337\/dci19-0080","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:15:46Z","timestamp":1584749746000},"page":"698-700","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":7,"title":["Improving Clinical Islet Transplantation Outcomes"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-8337","authenticated-orcid":false,"given":"Bart O.","family":"Roep","sequence":"first","affiliation":[{"name":"Department of Diabetes Immunology, Diabetes & Metabolism Research Institute at the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"},{"name":"Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"2022031223523688000_B1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"2022031223523688000_B2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031223523688000_B3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2213-8587(18)30112-8","article-title":"The challenge of modulating \u03b2-cell autoimmunity in type 1 diabetes","volume":"7","author":"Atkinson","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031223523688000_B4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.293.7.830","article-title":"Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes","volume":"293","author":"Hering","year":"2005","journal-title":"JAMA"},{"key":"2022031223523688000_B5","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.0608141103","article-title":"Correlation between \u03b2 cell mass and glycemic control in type 1 diabetic recipients of islet cell graft","volume":"103","author":"Keymeulen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031223523688000_B6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in \u03b2-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","author":"Vantyghem","year":"2019","journal-title":"Lancet"},{"key":"2022031223523688000_B7","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2337\/db09-0476","article-title":"Current advances and travails in islet transplantation","volume":"58","author":"Harlan","year":"2009","journal-title":"Diabetes"},{"key":"2022031223523688000_B8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"2022031223523688000_B9","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","article-title":"Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation","volume":"3","author":"Huurman","year":"2008","journal-title":"PLoS One"},{"key":"2022031223523688000_B10","doi-asserted-by":"crossref","first-page":"122146","DOI":"10.1172\/jci.insight.122146","article-title":"Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes","volume":"3","author":"Vecchio","year":"2018","journal-title":"JCI Insight"},{"key":"2022031223523688000_B11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/dc19-1480","article-title":"Targeting CXCR1\/2 does not improve insulin secretion after pancreatic islet transplantation: a phase 3, double-blind, randomized, placebo-controlled trial in type 1 diabetes","volume":"43","author":"Maffi","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031223523688000_B12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db14-0443","article-title":"CXCR1\/2 inhibition blocks and reverses type 1 diabetes in mice","volume":"64","author":"Citro","year":"2015","journal-title":"Diabetes"},{"key":"2022031223523688000_B13","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1172\/JCI63089","article-title":"CXCR1\/2 inhibition enhances pancreatic islet survival after transplantation","volume":"122","author":"Citro","year":"2012","journal-title":"J Clin Invest"},{"key":"2022031223523688000_B14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2249.2008.03812.x","article-title":"Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation","volume":"156","author":"Roelen","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2022031223523688000_B15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-6143.2011.03796.x","article-title":"Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice","volume":"12","author":"McCall","year":"2012","journal-title":"Am J Transplant"},{"key":"2022031223523688000_B16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nri1502","article-title":"Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes","volume":"4","author":"Roep","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2022031223523688000_B17","doi-asserted-by":"crossref","first-page":"237ra67","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Highfill","year":"2014","journal-title":"Sci Transl Med"},{"key":"2022031223523688000_B18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","article-title":"Islet inflammation and CXCL10 in recent-onset type 1 diabetes","volume":"159","author":"Roep","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2022031223523688000_B19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2249.2005.02883.x","article-title":"Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood","volume":"142","author":"Moberg","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2022031223523688000_B20","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/db16-0234","article-title":"National Institutes of Health\u2013sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities","volume":"65","author":"Ricordi","year":"2016","journal-title":"Diabetes"},{"key":"2022031223523688000_B21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/698\/532983\/dci190080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/698\/532983\/dci190080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:49:21Z","timestamp":1647143361000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/4\/698\/35839\/Improving-Clinical-Islet-Transplantation-Outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,12]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci19-0080","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]}}}